acquired resistance to third-generation egfr tkis in nsclc
Published 8 years ago • 293 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
3:07
third generation egfr tkis for acquired resistance
-
2:26
patterns of acquired resistance to egfr tkis in egfr mutation-positive nsclc
-
3:28
should third generation egfr inhibitors be used before or after progression?
-
1:33
acquired resistance to anti-egfr therapy in colorectal cancer
-
4:04
unmet needs in nsclc that egfr inhibitor bdtx-1535 aims to address
-
1:18
exploring neoadjuvant egfr-tkis in lung cancer
-
5:09
should a third generation egfr inhibitor be first line therapy for egfr mutation-positive nsclc?
-
21:09
mechanisms of resistance to egfr tki and new treatment strategies
-
4:48
third-generation egfr inhibitors in nsclc
-
6:14
third-generation egfr inhibitors in nsclc
-
2:55
phase 2 trial of bi 1482694 (hm61713), third-generation tki, in t790m-positive nsclc
-
2:15
jin-a02: a highly effective 4th generation egfr-tki, targeting egfr c797s triple mutation in nsclc
-
3:16
impact of new tkis on nsclc treatment planning
-
10:06
treating acquired resistance to tkis
-
4:10
3rd generation drug for acquired resistance in egfr lung cancer
-
8:37
acquired resistance to egfr-tki in lung cancer
-
24:36
treatment options for egfr t790m negative acquired resistance
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
2:23
therapeutic strategies for egfr-mutated lung cancer